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Laurence A. Boxer, a respected and beloved figure in the pediatric 1 
hematology/oncology community, died on January 9, 2017, after many years of 2 
treatment for multiple myeloma.  He had only recently retired from the University of 3 
Michigan Medical School, where he held the Henry and Mala Dorfman Family Chair 4 
in Pediatric Hematology/Oncology, a professorship established in part to recognize 5 
the extraordinary care he had provided to the Dorfman children. 6 
Larry grew up in Denver, CO, where his parents ran a mom and pop plumbing 7 
operation.  His father hoped he would enter the family business, but told him “if you 8 
cannot become a plumber, you can always become a doctor.” Larry chose the latter 9 
and attended Stanford Medical School, where he was later honored as the J. 10 
Wallace Sterling Outstanding Medical Alumnus of Stanford University.  He trained as 11 
a pediatric resident at Yale University, where he met his wife, Grace Jordison Boxer, 12 
a medical hematologist with whom he has shared a lifelong devotion to family, 13 
medicine, colleagues, students and travel. 14 
After Vietnam-era military service at Tripler Army Hospital in Honolulu, where he 15 
started to develop his research in neutrophil biology, he pursued fellowship training 16 
in pediatric hematology/oncology at Boston Children’s Hospital, then moved to 17 
Indiana University School of Medicine, where he and Robert Baehner established a 18 
powerhouse of phagocyte research and patient care.   In 1982, he came to Ann 19 
Arbor as professor and director of the division of pediatric hematology/oncology at 20 
the University of Michigan, where he has also served as associate chair for research 21 
and then associate chair for faculty affairs. 22 
  
Larry’s research focused on disorders of phagocyte number and function.  His 23 
contributions include major discoveries in the pathology, molecular biology, and 24 
treatment of phagocyte disorders including Chédiak-Higashi syndrome, secondary 25 
granule deficiency, and chronic granulomatous disease, as well as fundamental 26 
investigations into the biochemistry of neutrophil phagocytosis, granule sorting, and 27 
exocytosis.  His clinical research in neutropenia included the seminal clinical trial of 28 
granulocyte colony-stimulating factor (G-CSF) for severe congenital neutropenia 29 
and, through his leadership role in the Severe Chronic Neutropenia International 30 
Registry, influential investigations of the molecular basis of congenital neutropenia 31 
and the risks of myelodysplasia and myeloid leukemia in G-CSF-treated patients. His 32 
scientific accomplishments led to many awards and leadership positions in major 33 
academic societies including the Society for Pediatric Research (E. Mead Johnson 34 
Award), American Society of Pediatric Hematology Oncology (ASPHO Distinguished 35 
Career Award), American Society for Clinical Investigation, and, American Society of 36 
Hematology (ASH), and American Pediatric Society.  37 
Larry was also a gifted writer and editor, who served in many other editorial 38 
positions, including associate editor for the Journal of Clinical Investigation and the 39 
American Journal of Hematology; a member of the editorial boards of Pediatric Blood 40 
and Cancer, Current Opinion in Hematology, Hematotherapy and Stem Cell 41 
Research, Pediatrics in Review, and American Journal of Hematology; and member 42 
or chair of the publications committees for ASPHO and ASH. 43 
Although Larry did not follow an early inclination to be a rabbi, he became an 44 
extraordinarily devoted teacher and mentor.  In fact, during one of his final hospital 45 
admissions, he interrupted a resident’s history-taking to say, “Enough about me; tell 46 
  
me about your research!”  Junior faculty members and fellows who have trained or 47 
established their early careers under Dr. Boxer’s mentorship now lead major 48 
academic and pharmaceutical programs.  Of all of the many accolades during his 49 
career, none was more important to him than the individual relationships he had with 50 
his colleagues and the countless individuals he mentored during his career.  In 51 
December, 2016, Larry was honored with the ASH Mentorship award, 52 
acknowledging his accomplishments supporting the career development of others.  53 
Despite ill health and against all medical advice, Larry traveled to San Diego to 54 
receive this award as a coda to his career. 55 
Our community has lost a giant in pediatric medicine, an exemplary mentor, and a 56 
dear friend.  Larry Boxer's influence and impact will not be forgotten and his deep 57 
commitment to pediatric hematology and oncology will be felt for many years to 58 
come. 59 
 60 
CONFLICTS OF INTEREST: NONE 61 
 62 
FIGURE LEGEND: 63 
Figure 1.  Larry Boxer, MD 64 
  
 65 
 66 
